Feed aggregator

Lilly Wins Chinese Approval for Tirzepatide in Obesity on Heels of Novo’s Semaglutide

Biospace news - Mon, 07/22/2024 - 02:00

GSK Plots Blenrep’s Path Back to Market With EU Filing

Biospace news - Mon, 07/22/2024 - 02:00

SIGA, US Government Ink $113M Procurement Deal for Smallpox, Mpox Drug

Biospace news - Mon, 07/22/2024 - 02:00

Career Support, Development Trump Pay, According to Recent Reports

Biospace news - Mon, 07/22/2024 - 02:00

2024 Job Search Toolkit

Biospace news - Fri, 07/19/2024 - 02:00
BioSpace has updated our Job Search Toolkit, including recent resources to help you succeed with your next job search.

George Church Startup Nets $60M to Take Non-Standard Amino Acids to the Clinic

Biospace news - Fri, 07/19/2024 - 02:00

Boehringer Ingelheim Partners With GoodRx to Offer Humira Biosimilar at 92% Discount

Biospace news - Fri, 07/19/2024 - 02:00

AVEO’s Fotivda Combo Flunks Phase III Renal Cell Carcinoma Study

Biospace news - Fri, 07/19/2024 - 02:00

Updated: Artiva’s IPO Jumps to $167M

Biospace news - Fri, 07/19/2024 - 02:00

Phathom Scores Non-Erosive GERD Approval for Heartburn Drug

Biospace news - Thu, 07/18/2024 - 02:00

Despite Layoff Announcements, Novartis Beats Q2 Expectations

Biospace news - Thu, 07/18/2024 - 02:00

Who Is Driving The Bus - Drug Developers & Healthcare Providers or AI?

Biospace news - Thu, 07/18/2024 - 02:00

Future of Agenus’ Immunotherapy Combo Uncertain as FDA Discourages Accelerated Approval in CRC

Biospace news - Thu, 07/18/2024 - 02:00

Touting Shockwave’s Billion-Dollar Potential, J&J Lifts 2024 Guidance

Biospace news - Thu, 07/18/2024 - 02:00

Cassava Execs Step Down Amid DOJ Probe of Possible Alzheimer’s Drug Fraud

Biospace news - Thu, 07/18/2024 - 02:00

Newly Private NGM Bio Raises $122M for Registrational PSC Study

Biospace news - Wed, 07/17/2024 - 02:00

4DMT Unveils More Positive Data for Wet AMD Candidate

Biospace news - Wed, 07/17/2024 - 02:00

Pfizer’s Once-Daily Weight Loss Pill—Good Play or Bad?

Biospace news - Wed, 07/17/2024 - 02:00

Ongoing CRISPR Patent Dispute Complicates Licensing but Hasn’t Deterred Gene-Editing Investment

Biospace news - Wed, 07/17/2024 - 02:00

Roche Continues to Reap Rewards of Carmot Buyout with Strong Early GLP-1 Data

Biospace news - Wed, 07/17/2024 - 02:00